CAS 503860-57-9

Fórmula: C19H18FN5O2

InChI: InChI=1S/C19H18FN5O2/c1-24-18(26)10-16(15-6-7-21-12-22-15)23-19(24)25-8-9-27-17(11-25)13-2-4-14(20)5-3-13/h2-7,10,12,17H,8-9,11H2,1H3/t17-/m1/s1

Chave InChI: NKUNFNVAHJNALA-QGZVFWFLSA-N

SMILES: CN1C(=O)C=C(N=C1N2CCO[C@H](C2)C3=CC=C(C=C3)F)C4=NC=NC=C4

SAR502250

CAS: 503860-57-9

SAR502250

Fórmula: C₁₉H₁₈FN₅O₂

Pureza: 99.63%

Peso molecular: 367.38

Ref: 54-PC1032321

SAR502250

CAS: 503860-57-9

Fórmula: C₁₉H₁₈FN₅O₂

Pureza: 99.63%

Peso molecular: 367.3769

Ref: IN-DA01V7CC

SAR502250

CAS: 503860-57-9

SAR502250: potent, selective GSK3 inhibitor, IC50=12nM, oral, brain-penetrant, potential for AD research, antidepressant-like properties.

Fórmula: C₁₉H₁₈FN₅O₂

Cor e Forma: Solid

Peso molecular: 367.3769

Ref: TM-T35560

SAR502250

CAS: 503860-57-9

SAR502250 is a peptide that belongs to the group of inhibitors. It was originally isolated from a human monoclonal antibody and has been shown to bind to the extracellular domain of amyloid precursor protein (APP) and inhibit APP-mediated cell signaling. SAR502250 binds to the LRP-1 receptor, which is involved in lipid metabolism, inflammatory responses, and endocytosis. This drug exhibits agonist activity in some cells and an antagonist effect in others. The high purity of this compound makes it suitable for use as a research tool in various fields such as pharmacology, cell biology, or protein interactions.

Fórmula: C₁₉H₁₈FN₅O₂

Pureza: Min. 95%

Peso molecular: 367.4 g/mol

Ref: 3D-DVA86057